Sam-A Pharm. Co., Ltd (KOSDAQ:009300)

South Korea · Delayed Price · Currency is KRW

16,370

+20 (0.12%)

At close: Apr 29, 2026

-3.36% (1Y)

Market Cap	99.91B
Revenue (ttm)	77.80B
Net Income (ttm)	12.94B
Shares Out	6.10M
EPS (ttm)	2,120.00
PE Ratio	7.72
Forward PE	n/a
Dividend	850.00 (5.20%)
Ex-Dividend Date	Dec 29, 2025

Volume	6,188
Average Volume	4,936
Open	16,160
Previous Close	16,350
Day's Range	16,160 - 16,420
52-Week Range	14,730 - 19,250
Beta	0.24
RSI	58.95
Earnings Date	May 12, 2026

About Sam-A Pharm.

Sam-A Pharm. Co., Ltd operates as a pharmaceutical company in South Korea. The company offers a range of pharmaceutical products in the areas of respiratory, antibiotics, anti-virals, anti-histamines, anti-fungals, dermatology, pain/inflammation, gastrointestinal, cardiovascular, metabolism, urological, and steroids, as well as psychotropic agents; and OTC products in the areas of respiratory, ant-analgesics, gastro-intestinal, topical, oral, and anti-histamines. It provides NOMA MEGAFFECT for stress relief, eye care, memory and blood lipid con... [Read more]

Industry Pharmaceutical Preparations

Founded 1945

Employees 300

Stock Exchange KOSDAQ

Ticker Symbol 009300

Full Company Profile

Financial Performance

In 2025, Sam-A Pharm.'s revenue was 77.80 billion, a decrease of -18.60% compared to the previous year's 95.58 billion. Earnings were 12.94 billion, a decrease of -41.39%.

Financial Statements

News

There is no news available yet.